Herbert M. Lazarus, MD

About Me

Conditions and Treatments

lupus erythematosus, Lyme disease

Credentials

Positions
  • Clinical Associate Professor, Department of Pediatrics
  • Division Dir Pediatric Rheumatology
Board Certifications
  • American Board of Pediatrics - Pediatrics, 1987
Education and Training
  • Fellowship, Hospital for Joint Diseases, Peds Rheumatology, 1988
  • Residency, New York University Medical Center, Pediatrics, 1986
  • MD from Umdnj, 1983
Departments

Locations and Appointments

18 Insurance Plans Accepted
  • Aetna HMO
  • Aetna Indemnity
  • Aetna Medicare
  • Aetna POS
  • Aetna PPO/EPO
  • Cigna EPO/POS
  • Cigna PPO
  • Oxford Exchange
  • Oxford Freedom
  • Oxford Liberty
  • Oxford Medicare
  • United Exchange- Compass
  • UnitedHealthcare EPO
  • UnitedHealthcare HMO
  • UnitedHealthcare Medicare
  • UnitedHealthcare POS
  • UnitedHealthcare PPO
  • UnitedHealthcare Top Tier
*Insurance listed above may not be accepted at all office locations. Please confirm prior to each visit. The information presented here may not be complete or may have been changed.
Pediatric & Adolescent Medicine,

390 West End Avenue, Suite 1E
New York, NY 10024

Contact

Phone: 212-787-1444

Pediatric & Adolescent Medicine,

495 Central Park Avenue, Suite 305
Scarsdale, NY 10583

Contact

Phone: 914-725-7555

Welcome back!

As a returning patient for this doctor, please schedule an appointment using your MyChart at NYU Langone account.

Learn more about MyChart at NYU Langone.

Publications

  • Low CD34 cell dose is associated with higher non-relapse and overall mortality after reduced intensity conditioning hematopoietic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome [Meeting Abstract]

    Torlen, J; Ringden, O; Le-Rademacher, J; Battiwalla, M; Chen, J; Ho, V T; Kebriaei, P; Keever-Taylor, C A; Kindwall-Keller, T L; Lazarus, H M; Laughlin, M; Lill, M C; O'Brien, T; Perales, M -A; Rocha, V; Savani, B N; Szwajcer, D; Valcarcel, D; Eapen, M
    Bone marrow transplantation. 2014 March. 49: S229-S230

  • Low CD34 cell dose is associated with higher non-relapse and overall mortality after reduced intensity conditioning hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndrome [Meeting Abstract]

    Thorlen, J; Ringden, O; Le, Rademacher J; Battiwalla, M; Chen, J; Ho, V T; Kebriaei, P; Keever-Taylor, C A; Kindwall-Keller, T L; Lazarus, H M; Laughlin, M J; Lill, M; O'Brien, T A; Perales, M A; Rocha, V; Savani, B N; Szwajcer, D; Valcarcel, D; Eapen, M
    Blood. 2013 21 Oct. 122 (21):

  • Trends in allogeneic Stem cell transplantation for multiple myeloma: A CIBMTR analysis

    Kumar S.; Zhang M.-J.; Li P.; Dispenzieri A.; Milone G.A.; Lonial S.; Krishnan A.; Maiolino A.; Wirk B.; Weiss B.; Freytes C.O.; Vogl D.T.; Vesole D.H.; Lazarus H.M.; Meehan K.R.; Hamadani M.; Lill M.; Callander N.S.; Majhail N.S.; Wiernik P.H.; Nath R.; Kamble R.T.; Vij R.; Kyle R.A.; Gale R.P.; Hari P.N.
    Blood. 2011. 118 (7): 1979-1988

Read All Publications (13)